शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ENTERONSEEntero Healthcare Solutions Limited· RetailingHighNeutral
Announced Wed, 12 Nov, 2025 · 19:02 IST

Entero Q2 FY26 Results: Consolidated PAT up 41% YoY, Revenue up 21% YoY

Profit growth above 25%Negative operating cash flowResults View source PDFExplain this filing

ENTERO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.9%Reaction day
₹1136.50
prior close
₹1156.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%+1.0% vs market
Retailing peers, median of 57sector · industry level-0.9%+1.8% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 1.8 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
-1.9
15m
-1.9
30m
-2.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.9-0.1+1.0-0.9+1.8
Next day
-0.3-0.2-0.1-0.9+0.6
2d
+0.3+0.4-0.1-0.7+1.0
3d
-0.4-0.4-0.0-1.3+0.9
4d
-4.3-0.6-3.7-1.3-3.0
5d
-5.9-0.9-5.0-2.0-3.8
1w
-7.4-3.0-4.4-3.7-3.8
15d
-8.5-3.9-4.6-5.3-3.2
1m
-11.6-4.8-6.8-5.4-6.2
2m
+7.4-7.8+15.2-8.8+16.2
3m
+0.4-7.2+7.6-12.4+12.8
UpDownMarket · Nifty Microcap 250Sector · Retailing peers, median of 57Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated Q2 FY26 revenue grew 21% YoY to Rs. 15,709 million and H1 revenue grew 24% to Rs. 29,748 million. Consolidated PAT jumped 41% in Q2 to Rs. 366 million and 43% in H1 to Rs. 668 million. Standalone revenue declined 26% YoY in Q2 and 31% in H1. Operating cash flows were negative on both standalone (minus Rs. 382 million) and consolidated (minus Rs. 673 million) basis. Auditor MSKA gave an unmodified review conclusion.

Likely market impact

Mixed picture. Strong consolidated growth driven by acquisitions masks weak standalone performance and negative operating cash flows.